Prof Woo Keng Thye

About Doctor

Professor Woo Keng Thye, MBBS (NUS), M Med, FRACP (Nephrology) was trained at the Royal Melbourne Hospital in Australia. He is Emeritus Consultant and Advisor to Dept of Renal Medicine, Singapore General Hospital is also Clinical Professor in Medicine at the National University of Singapore. 

He has been a practicing Nephrologist for more than 30 years. He has been Head, Dept of Renal Medicine at the Singapore General Hospital from 1989 – 2002 and Chairman, Division of Medicine from 2000 to 2003. He was Chairman of the National Medical Research Council from 2003 – 2006 and is presently on the Board of Directors of the National Kidney Foundation since 2005. He has published extensively and has authored several books including kidney books, short stories and novels 2007. His hobbies include writing and culturing bonsai.

Languages Spoken

• English

Professional Appointments and Committee Memberships

• ​Head, Dept of Renal Medicine, SGH – 1989 - 2002 
• Chairman Division of Medicine, SGH – 2000 - 2003 
  
• Chairman, Division of Research, SGH – 2001 – 2003 
  
• Chairman, Renal Specialist Accreditation Committee – 1998 – 2005 
  
• Chairman, National Committee on Renal Care (NCRC) – 1996 – 2005 
  
• Chairman, National Medical Research Council (NMRC) 2003 – 2006 
  
• Member, National Medical Research Council (NMRC) – 1994 – 2000 
  
• Chairman, Medical Clinical Research Committee (MCRC) since 1997 – Present 
  
• Member, Medical Clinical Research Committee (MCRC) – 1993 – 1995 
  
• Board of Directors – National Kidney Foundation since 2005 – Present 
  

Awards

• Galloway Memorial Lecture 1984 
  
• Public Administration Medal (Silver) National Day Award 2002
  
• Inaugural Kincaid-Smith Award for Scientific Contribution – 2005
  
• 3rd College of Physicians Lecture : Translational Research - 2006
  
• Singapore Medical Association (SMA) Lecturer : Physician Leadership – 2007
  
  

Publications

Since 1976 he has been involved in research in kidney diseases in the area of Immunology Proteimuria and for past 8 years in Genomics and Proteinuria. Areas of interest include IgA nephritis and other forms of glomerulonephritis. Have focused on drug therapy and clinical trials to retard and prevent renal failure.

•  K T Woo, B J R Junor, H Salem, A J F d'Apice, J A Whitworth, Priscilla, Kincaid-Smith. Beta-Thromboglobulin and Platelet Aggregates in Glomerulonephritis. Clinical Nephrology, 1980, 14, 9295. 
  
• K T Woo, Y O Tan, H K Yap, Y K Lau, C H Lim. Beta-Thromboglobulin in IgA Nephritis. Thrombosis Research, 1982, 24(3), 295-262.
  
• K T Woo, Y O Tan, H K Yap, Y K Lau, J S H TAY, C H Lim. Beta-2-Microglobulin in IgA Nephritis. Nephron, 1984, 37 : 78-81.
  
• K T Woo, E J C Lee, Y K Lau, C H Lim. Beta-2-microglobulin in the assessment of renal function of the transplanted kidney. Nephron, 1985, 39:223-227.
  
• K T Woo, S S Wei, E J C Lee, Y K Lau, C H Lim. The effects of hemodialysis and peritoneal dialysis on antithrombin and platelets. Nephron, 1985, 40:25-28.
  
• K T Woo, E J C Lee, Y K Lau, C H Lim. Antithrombin III in IgA Nephritis. Thrombosis Research, 1985, 40:483-487.
  
• K T Woo, E J C Lee, Y K Lau, C H Lim. Antithrombin III in Renal Transplant Recipients. Thrombosis Research, 1985, 38:201-206.
  
• K T Woo, R P S Edmondson, A Y T Wu, G S C Chiang, H S Pwee, C H Lim. The Natural History of IgA Nephritis in Singapore. Clin Nephrol, 1986, 25:15-21.
  
• K T Woo, A Y T Wu, Y K Lau, E J C Lee, R P S Edmondson, H S Pwee, C H Lim. Protein Selectivity in IgA Nephropathy. Nephron, 1986, 42:236-239.
  
• K T Woo, R P S Edmondson, H K Yap, A Y T Wu, G S C Chiang, E J C Lee, H S Pwee, C H Lim. Effects on Triple Therapy on the progression of Mesangial Proliferative Glomerulonephritis. Clin Nephrol, 1987, 27:56-64.
  
• K T Woo, Y K Lau, H K Yap, G S L Lee, G S C Chiang, C H Lim. Protein Selectivity : A Prognostic Index in IgA nephritis. Nephron 1989, 52:300-306.
  
• K T Woo, G S L Lee, Y K Lau, G S C Chiang, C H Lim. Effects of Triple Therapy in IgA Nephritis : A Follow Up Study 5 years later, Clin Nephrol, 1991, 36:60-66.
  
• K T Woo, Y K Lau, G S L Lee, S S Wei, C H Lim. Pattern of Proteinuria in IgA Nephritis by SDS-AGE : Clinical Significance. Clin Nephrol, 1991, 36:6-11.
  
• K T Woo, Y K Lau, K S Wong, Y M Chin, G S C Chiang, C H Lim. Isoelectric focussing and protein selectivity index as predictors of response to therapy in IgA Nephrotic Syndrome. Nephron, 1994, 67, 408-413
  
• KT Woo, YK Lau, GSL Lee, KS Wong, SS Wei, GSC Chiang, CH Lim. Pattern of Proteinuria in IgA Nephropathy, Nephrology 1997; 3, 31 -34.
  
• KT Woo, GSC Chiang, AA Pall, PH Tan, YK Lau, YM Chin. The Changing Pattern of Glomerulonephritis in Singapore over the past 2 decades, Clinical Nephrology, 1999, 52, 96 - 102
  
• KT Woo, YK Lau, KS Wong, GSC Chiang. ACEI/ATRA Therapy Decreases Proteinuria by Improving Glomerular Permselectivity in IgA Nephritis. Kidney International, 2000, 58, 2485 - 2491
  
• KT Woo, YK Lau, Y Zhao, FE Liu, HB Tan, EK Tan, S Fook-Chong, CM Chan, KS Wong. Disease Progression, Response to ACEI/ATRA Therapy and Influence of ACE gene in IgA Nephritis. Cellular & Molecular Biology 2007; 4(3):227-232
  
• Woo KT, Chan CM, Choong HL, Tan HK, Foo M, Lee EJC, Tan CC, Lee GSL, Tan SH, Vathsala A, Lim CH, Chiang GSC, Fook-Chong S, Yi Z, Tan HB, Wong KS. High Dose Losartan and ACE gene polymorphism in IgA nephritis. Genomic Medicine, 2009, 2 (3): 77-81. GSL, Tan SH, Lim CH, Chiang GSC, Fook – Chong S, Wong KS.
  
• Woo KT, Chan CM, Tan HK, Choong HL, Foo M, Vathsala A, Lee EJC, Tan CC, Lee GSL, Tan SH, Lim CH, Chiang GSC, Fook – Chong S, Wong KS. Beneficial effects of high dose losartan in IgA nephritis. Clinical Nephrol 2009, 71 (6): 617-624